Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick Kaiser

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Heart (British Cardiac Society)|May 8, 2021
Lipoprotein(a) is robustly associated with aortic valve calciumYannick Kaiser, Sunny S Singh, Kang H Zheng, et al.
European Heart Journal|July 23, 2022
Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcificationYannick Kaiser, Janine E van der Toorn, Sunny S Singh, et al.
Atherosclerosis|February 3, 2022
Reduced baroreflex sensitivity and increased splenic activity in patients with severe obstructive sleep apneaYannick Kaiser, Kim E Dzobo, Madeline J L Ravesloot, et al.
Clinical Epigenetics|November 11, 2020
BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetesSylwia Wasiak, Kim E Dzobo, Brooke D Rakai, et al.
Circulation. Genomic and Precision Medicine|July 19, 2021
Sex-Specific Associations of Genetically Predicted Circulating Lp(a) (Lipoprotein(a)) and Hepatic <i>LPA</i> Gene Expression Levels With Cardiovascular Outcomes: Mendelian Randomization and Observational AnalysesJakie Guertin, Yannick Kaiser, Hasanga Manikpurage, et al.
EJNMMI Research|November 19, 2024
First-in-human study of <sup>99m</sup>Tc-labeled fucoidan, a SPECT tracer targeting P-selectinReindert F Oostveen, Kang H Zheng, Yannick Kaiser, et al.
Diabetologia|August 15, 2023
Atorvastatin lowers <sup>68</sup>Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetesReindert F Oostveen, Yannick Kaiser, Mia R Ståhle, et al.
Journal of Clinical Lipidology|September 24, 2025
Human monocyte inflammation in patients with Lp(a) or atherosclerotic cardiovascular disease is not accompanied by changes in chromatin accessibility in circulating classical monocytesRosalie W M Kempkes, Jordan M Kraaijenhof, Bram W van Os, et al.
BMJ Open|February 23, 2021
Cardiovascular risk factors and COVID-19 outcomes in hospitalised patients: a prospective cohort studyDidier Collard, Nick S Nurmohamed, Yannick Kaiser, et al.
Atherosclerosis|September 12, 2020
No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levelsKang H Zheng, Yannick Kaiser, Casper C van Olden, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Heart (British Cardiac Society)|May 8, 2021
Lipoprotein(a) is robustly associated with aortic valve calciumYannick Kaiser, Sunny S Singh, Kang H Zheng, et al.
European Heart Journal|July 23, 2022
Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcificationYannick Kaiser, Janine E van der Toorn, Sunny S Singh, et al.
Atherosclerosis|February 3, 2022
Reduced baroreflex sensitivity and increased splenic activity in patients with severe obstructive sleep apneaYannick Kaiser, Kim E Dzobo, Madeline J L Ravesloot, et al.
Clinical Epigenetics|November 11, 2020
BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetesSylwia Wasiak, Kim E Dzobo, Brooke D Rakai, et al.
Circulation. Genomic and Precision Medicine|July 19, 2021
Sex-Specific Associations of Genetically Predicted Circulating Lp(a) (Lipoprotein(a)) and Hepatic <i>LPA</i> Gene Expression Levels With Cardiovascular Outcomes: Mendelian Randomization and Observational AnalysesJakie Guertin, Yannick Kaiser, Hasanga Manikpurage, et al.
EJNMMI Research|November 19, 2024
First-in-human study of <sup>99m</sup>Tc-labeled fucoidan, a SPECT tracer targeting P-selectinReindert F Oostveen, Kang H Zheng, Yannick Kaiser, et al.
Diabetologia|August 15, 2023
Atorvastatin lowers <sup>68</sup>Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetesReindert F Oostveen, Yannick Kaiser, Mia R Ståhle, et al.
Journal of Clinical Lipidology|September 24, 2025
Human monocyte inflammation in patients with Lp(a) or atherosclerotic cardiovascular disease is not accompanied by changes in chromatin accessibility in circulating classical monocytesRosalie W M Kempkes, Jordan M Kraaijenhof, Bram W van Os, et al.
BMJ Open|February 23, 2021
Cardiovascular risk factors and COVID-19 outcomes in hospitalised patients: a prospective cohort studyDidier Collard, Nick S Nurmohamed, Yannick Kaiser, et al.
Atherosclerosis|September 12, 2020
No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levelsKang H Zheng, Yannick Kaiser, Casper C van Olden, et al.
Pageof 4